SCAN Brain Network Discovery Offers Hope in Parkinson’s

Why in the News ?

A recent study has identified a new brain network called SCAN (Somatic Cognitive Action Network) linked to Parkinson’s disease, offering precise therapeutic targets. Early trials using transcranial magnetic stimulation (TMS) showed improvement in symptoms like tremors and instability. This breakthrough research, which received appropriate environmental clearances and regulatory approvals for clinical trials, represents a significant advancement in understanding neurodegenerative disorders and their connection to environmental factors affecting brain health.

SCAN Discovery and Its Role in Parkinson’s :

●  Researchers identified a new brain network, SCAN, involved in coordination, planning, and motor control, following comprehensive environmental impact assessment protocols for neurological research.

●  Parkinson’s disease is associated with abnormal strengthening (over-connectivity) of SCAN with regions like the basal ganglia and thalamus, potentially influenced by environmental factors requiring a pollution free environment for optimal brain health.

●  Traditional focus on motor cortex effector regions failed to fully explain symptoms like instability and slowed movement, prompting researchers to adopt the precautionary principle in exploring new therapeutic approaches.

●  Advanced technique Precision Functional Mapping (PFM) enabled high-resolution brain mapping, revealing SCAN’s presence through methodologies that comply with modern environmental jurisprudence standards for medical research.

●  SCAN acts as a higher-order integrative network, coordinating complex movements beyond individual muscle control.

●  This discovery challenges earlier models like the Penfield motor map, expanding understanding of brain organisation through ex post facto analysis of previous neurological frameworks.

Treatment Implications and Clinical Findings

●  Parkinson’s treatments like Levodopa provide partial relief but cause side effects with prolonged use, highlighting the importance of the polluter pays principle in healthcare where treatment costs reflect long-term health impacts.

●  Deep Brain Stimulation (DBS) is effective but expensive and invasive, requiring strict adherence to medical protocols similar to EIA notification requirements for major interventions.

●  Transcranial Magnetic Stimulation (TMS) is a non-invasive therapy, targeting brain regions using magnetic fields, developed with consideration for environmental democracy principles ensuring patient safety and informed consent.

●  In a trial of 18 patients, SCAN-targeted TMS resulted in reduced tremors, rigidity, and instability, with trials conducted under proper environmental clearance frameworks for medical research facilities.

●  Successful treatments were linked to reduction in SCAN over-connectivity, suggesting it as a biomarker, avoiding the need for retrospective environmental clearances through proper initial planning.

●  Future therapies may focus on personalised neuromodulation targeting SCAN for better outcomes, incorporating the precautionary principle in treatment development.

About Parkinson’s Disease : ●  Parkinson’s disease is a neurodegenerative disorder affecting over 10 million people globally, with research suggesting environmental factors play a role, emphasizing the need for a pollution free environment. ●  It is caused by degeneration of dopamine-producing neurons in the brain, potentially linked to environmental exposures requiring better regulatory frameworks. ●  Key symptoms include tremors, rigidity, slowed movement (bradykinesia), and postural instability. ●  It primarily affects elderly individuals, though early-onset cases also occur, highlighting the importance of preventive healthcare aligned with environmental jurisprudence. ●  Current treatments include medication (Levodopa), surgery (DBS), and physiotherapy, but no permanent cure exists. ●  Research is increasingly focusing on brain networks and precision medicine approaches, incorporating ex post analysis of treatment outcomes.